aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Pharmaceuticals
Tags
Biotech
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Stargazer Pharmaceuticals founded?
Stargazer Pharmaceuticals was founded in 2018.
Where is Stargazer Pharmaceuticals’s headquarters located?
Stargazer Pharmaceuticals’s headquarters is located in Boston, MA, US.
When was Stargazer Pharmaceuticals’s last funding round?
Stargazer Pharmaceuticals’s most recent funding round was for $57M (USD) in November 2020.
How many employees does Stargazer Pharmaceuticals have?
Stargazer Pharmaceuticals has 6 employees as of Feb 5, 2024.
How much has Stargazer Pharmaceuticals raised to-date?
As of July 05, 2023, Stargazer Pharmaceuticals has raised a total of $94.2M (USD) since Nov 9, 2020.
Add Comparison
Total Raised to Date
$94.2M
USD
Last Update Nov 9, 2020
Last Deal Details
$57M
USD
Nov 9, 2020
Series A
Total Employees Over Time
6
As of Feb 2024
Stargazer Pharmaceuticals Address
200 Clarendon Street
mailbox 30 Floor 45
Boston,
Massachusetts
02215
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts